Treatment of dehiscences and fenestrations around dental implants using resorbable and nonresorbable membranes associated with bone autografts: a comparative clinical study.
Identifieur interne : 003E73 ( PubMed/Corpus ); précédent : 003E72; suivant : 003E74Treatment of dehiscences and fenestrations around dental implants using resorbable and nonresorbable membranes associated with bone autografts: a comparative clinical study.
Auteurs : M. Simion ; U. Misitano ; L. Gionso ; A. SalvatoSource :
- The International journal of oral & maxillofacial implants [ 0882-2786 ]
English descriptors
- KwdEn :
- Adult, Biocompatible Materials, Bone Regeneration, Bone Transplantation (methods), Dental Implantation, Endosseous (adverse effects), Dental Implants (adverse effects), Humans, Jaw, Edentulous, Partially (surgery), Lactic Acid, Mandibular Diseases (surgery), Maxillary Diseases (etiology), Maxillary Diseases (surgery), Membranes, Artificial, Middle Aged, Polyesters, Polyglycolic Acid, Polymers, Polytetrafluoroethylene, Reoperation, Surgical Wound Dehiscence (etiology), Surgical Wound Dehiscence (surgery), Transplantation, Autologous.
- MESH :
- chemical , adverse effects : Dental Implants.
- chemical : Biocompatible Materials, Lactic Acid, Membranes, Artificial, Polyesters, Polyglycolic Acid, Polymers, Polytetrafluoroethylene.
- adverse effects : Dental Implantation, Endosseous.
- etiology : Maxillary Diseases, Surgical Wound Dehiscence.
- methods : Bone Transplantation.
- surgery : Jaw, Edentulous, Partially, Mandibular Diseases, Maxillary Diseases, Surgical Wound Dehiscence.
- Adult, Bone Regeneration, Humans, Middle Aged, Reoperation, Transplantation, Autologous.
Abstract
This study was carried out to evaluate the efficacy of poly(lactic acid) and poly(glycolic acid) (PLA/PGA) resorbable membranes in conjunction with autogenous bone grafts when used for the treatment of implant dehiscences and/or fenestrations. Nine patients with a total of 18 implants participated. Nine implants were associated with dehiscences, and 9 with fenestrations; 16 implants were in the maxilla, and 2 in the mandible. Nine defects were treated with PLA/PGA membranes (test group), and the nine were treated with expanded polytetrafluoroethylene (e-PTFE) membranes (control group). Second-stage surgery was performed after 6 to 7 months of healing. Overall results of the regenerative therapy of the 18 defects showed a highly significant (P < .001) defect reduction, with a 93.38% (SD = 15.88) bone fill. A slightly higher percentage of bone fill was found in the e-PTFE group (98.20%) than in the PLA/PGA group (88.56%), but the difference was not statistically significant (P = .207). This study demonstrated that resorbable PLA/PGA membranes can be equally effective as e-PTFE in the treatment of implant dehiscences and fenestrations when associated with autogenous bone chips.
PubMed: 9109265
Links to Exploration step
pubmed:9109265Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of dehiscences and fenestrations around dental implants using resorbable and nonresorbable membranes associated with bone autografts: a comparative clinical study.</title><author><name sortKey="Simion, M" sort="Simion, M" uniqKey="Simion M" first="M" last="Simion">M. Simion</name><affiliation><nlm:affiliation>Department of Dentistry, University of Milan, San Raffaele Hospital, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Misitano, U" sort="Misitano, U" uniqKey="Misitano U" first="U" last="Misitano">U. Misitano</name></author><author><name sortKey="Gionso, L" sort="Gionso, L" uniqKey="Gionso L" first="L" last="Gionso">L. Gionso</name></author><author><name sortKey="Salvato, A" sort="Salvato, A" uniqKey="Salvato A" first="A" last="Salvato">A. Salvato</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>1997 Mar-Apr</MedlineDate></PubDate></date><idno type="RBID">pubmed:9109265</idno><idno type="pmid">9109265</idno><idno type="wicri:Area/PubMed/Corpus">003E73</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003E73</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Treatment of dehiscences and fenestrations around dental implants using resorbable and nonresorbable membranes associated with bone autografts: a comparative clinical study.</title><author><name sortKey="Simion, M" sort="Simion, M" uniqKey="Simion M" first="M" last="Simion">M. Simion</name><affiliation><nlm:affiliation>Department of Dentistry, University of Milan, San Raffaele Hospital, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Misitano, U" sort="Misitano, U" uniqKey="Misitano U" first="U" last="Misitano">U. Misitano</name></author><author><name sortKey="Gionso, L" sort="Gionso, L" uniqKey="Gionso L" first="L" last="Gionso">L. Gionso</name></author><author><name sortKey="Salvato, A" sort="Salvato, A" uniqKey="Salvato A" first="A" last="Salvato">A. Salvato</name></author></analytic><series><title level="j">The International journal of oral & maxillofacial implants</title><idno type="ISSN">0882-2786</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Biocompatible Materials</term><term>Bone Regeneration</term><term>Bone Transplantation (methods)</term><term>Dental Implantation, Endosseous (adverse effects)</term><term>Dental Implants (adverse effects)</term><term>Humans</term><term>Jaw, Edentulous, Partially (surgery)</term><term>Lactic Acid</term><term>Mandibular Diseases (surgery)</term><term>Maxillary Diseases (etiology)</term><term>Maxillary Diseases (surgery)</term><term>Membranes, Artificial</term><term>Middle Aged</term><term>Polyesters</term><term>Polyglycolic Acid</term><term>Polymers</term><term>Polytetrafluoroethylene</term><term>Reoperation</term><term>Surgical Wound Dehiscence (etiology)</term><term>Surgical Wound Dehiscence (surgery)</term><term>Transplantation, Autologous</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dental Implants</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Biocompatible Materials</term><term>Lactic Acid</term><term>Membranes, Artificial</term><term>Polyesters</term><term>Polyglycolic Acid</term><term>Polymers</term><term>Polytetrafluoroethylene</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Dental Implantation, Endosseous</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Maxillary Diseases</term><term>Surgical Wound Dehiscence</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Bone Transplantation</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Jaw, Edentulous, Partially</term><term>Mandibular Diseases</term><term>Maxillary Diseases</term><term>Surgical Wound Dehiscence</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Bone Regeneration</term><term>Humans</term><term>Middle Aged</term><term>Reoperation</term><term>Transplantation, Autologous</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study was carried out to evaluate the efficacy of poly(lactic acid) and poly(glycolic acid) (PLA/PGA) resorbable membranes in conjunction with autogenous bone grafts when used for the treatment of implant dehiscences and/or fenestrations. Nine patients with a total of 18 implants participated. Nine implants were associated with dehiscences, and 9 with fenestrations; 16 implants were in the maxilla, and 2 in the mandible. Nine defects were treated with PLA/PGA membranes (test group), and the nine were treated with expanded polytetrafluoroethylene (e-PTFE) membranes (control group). Second-stage surgery was performed after 6 to 7 months of healing. Overall results of the regenerative therapy of the 18 defects showed a highly significant (P < .001) defect reduction, with a 93.38% (SD = 15.88) bone fill. A slightly higher percentage of bone fill was found in the e-PTFE group (98.20%) than in the PLA/PGA group (88.56%), but the difference was not statistically significant (P = .207). This study demonstrated that resorbable PLA/PGA membranes can be equally effective as e-PTFE in the treatment of implant dehiscences and fenestrations when associated with autogenous bone chips.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">9109265</PMID><DateCompleted><Year>1997</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0882-2786</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><MedlineDate>1997 Mar-Apr</MedlineDate></PubDate></JournalIssue><Title>The International journal of oral & maxillofacial implants</Title><ISOAbbreviation>Int J Oral Maxillofac Implants</ISOAbbreviation></Journal><ArticleTitle>Treatment of dehiscences and fenestrations around dental implants using resorbable and nonresorbable membranes associated with bone autografts: a comparative clinical study.</ArticleTitle><Pagination><MedlinePgn>159-67</MedlinePgn></Pagination><Abstract><AbstractText>This study was carried out to evaluate the efficacy of poly(lactic acid) and poly(glycolic acid) (PLA/PGA) resorbable membranes in conjunction with autogenous bone grafts when used for the treatment of implant dehiscences and/or fenestrations. Nine patients with a total of 18 implants participated. Nine implants were associated with dehiscences, and 9 with fenestrations; 16 implants were in the maxilla, and 2 in the mandible. Nine defects were treated with PLA/PGA membranes (test group), and the nine were treated with expanded polytetrafluoroethylene (e-PTFE) membranes (control group). Second-stage surgery was performed after 6 to 7 months of healing. Overall results of the regenerative therapy of the 18 defects showed a highly significant (P < .001) defect reduction, with a 93.38% (SD = 15.88) bone fill. A slightly higher percentage of bone fill was found in the e-PTFE group (98.20%) than in the PLA/PGA group (88.56%), but the difference was not statistically significant (P = .207). This study demonstrated that resorbable PLA/PGA membranes can be equally effective as e-PTFE in the treatment of implant dehiscences and fenestrations when associated with autogenous bone chips.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Simion</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Dentistry, University of Milan, San Raffaele Hospital, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Misitano</LastName><ForeName>U</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Gionso</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Salvato</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Oral Maxillofac Implants</MedlineTA><NlmUniqueID>8611905</NlmUniqueID><ISSNLinking>0882-2786</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001672">Biocompatible Materials</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015921">Dental Implants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008567">Membranes, Artificial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011091">Polyesters</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011108">Polymers</NameOfSubstance></Chemical><Chemical><RegistryNumber>26009-03-0</RegistryNumber><NameOfSubstance UI="D011100">Polyglycolic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>33X04XA5AT</RegistryNumber><NameOfSubstance UI="D019344">Lactic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>459TN2L5F5</RegistryNumber><NameOfSubstance UI="C033616">poly(lactide)</NameOfSubstance></Chemical><Chemical><RegistryNumber>9002-84-0</RegistryNumber><NameOfSubstance UI="D011138">Polytetrafluoroethylene</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001672" MajorTopicYN="N">Biocompatible Materials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001861" MajorTopicYN="N">Bone Regeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016025" MajorTopicYN="Y">Bone Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003758" MajorTopicYN="N">Dental Implantation, Endosseous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015921" MajorTopicYN="N">Dental Implants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007576" MajorTopicYN="N">Jaw, Edentulous, Partially</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019344" MajorTopicYN="N">Lactic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008336" MajorTopicYN="N">Mandibular Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008439" MajorTopicYN="N">Maxillary Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008567" MajorTopicYN="Y">Membranes, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011091" MajorTopicYN="N">Polyesters</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011100" MajorTopicYN="N">Polyglycolic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011108" MajorTopicYN="N">Polymers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011138" MajorTopicYN="N">Polytetrafluoroethylene</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013529" MajorTopicYN="N">Surgical Wound Dehiscence</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014182" MajorTopicYN="N">Transplantation, Autologous</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1997</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1997</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9109265</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003E73 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003E73 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:9109265
|texte= Treatment of dehiscences and fenestrations around dental implants using resorbable and nonresorbable membranes associated with bone autografts: a comparative clinical study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:9109265" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a EdenteV2
| This area was generated with Dilib version V0.6.32. |  |